Spotlight
Topics
DI Executive
Subscribe
- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Catheter with Integrated Intravascular Ultrasound Technology
Combining a support crossing catheter with intravascular ultrasound imaging, the Provisio SLT IVUS System offers simultaneous real-time visualization and measurement of vessel lumen.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Provisio SLT IVUS System, which features a support crossing catheter that integrates intravascular ultrasound, enabling clinicians to assess blood vessel lumen and obtain vessel measurements at the same time through Sonic Lumen Tomography (SLT).
Provisio Medical , the manufacturer of the Proviso SLT IVUS System, said the Provisio SLT IVUS System’s inclusion of the SLT IVUS Support Crossing Catheter provides dual functionality in interventional procedures with an ultrasound transducer array at the distal end of the catheter.
Through the use of Sonic Lumen Tomography (SLT), the newly FDA-cleared Provisio SLT IVUS System provides clinicians with simultaneous real-time visualization and measurement of vessel lumen during interventional procedures for patients with peripheral vascular disease. (Image courtesy of Provisio Medical.)
Incorporating intravascular ultrasound capability into a front-line support crossing catheter may help simplify workflows, reduce iodinated contrast media (ICM) and reduce radiation exposure for patients being treated for peripheral vascular disease (PVD), according to Provisio Medical.
"Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. Eric Ryan, M.D., the chief executive officer of Provisio Medical. "Thanks to the ease-of-use of SLT IVUS, which can be incorporated more efficiently in the peripheral vascular workflow, we believe there is the possibility of increased adoption and therefore improved outcomes for many more patients with potentially devastating peripheral vascular disease."
Related Videos
Related Content
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024Article
A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Contrast-Enhanced Mammography and Dense Breasts: What a New Meta-Analysis Reveals
May 1st 2024Article
The 10-study meta-analysis demonstrated that contrast-enhanced mammography has a 95 percent sensitivity rate and an 81 percent specificity rate for diagnosing suspicious lesions in women with dense breasts.
